pregnancy complications (5), although many women may be unaware that their condition has any implications for fetal or maternal health. A recent systematic review has suggested that women with CKD have at least at twofold higher risk of developing adverse fetal outcomes compared with women without CKD, and that adverse maternal events were more than fivefold higher (6). It is impractical for obstetric nephrologists, obstetric physicians or obstetricians to undertake counseling for every woman with CKD; therefore, those with CKD stages 1 and 2 without adverse risk factors can be managed by their general practitioner or primary care physician. Table I lists the clinical situations where pre-pregnancy counseling is essential, and these are the focus of this review. Although estimations of glomerular filtration rate (GFR; by the Modification of Diet in Renal Disease [MDRD] Study (7) or Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI] (8) equations) significantly underestimate true GFR in pregnancy as measured by inulin or 24-hour creatinine clearance, a more accurate assessment of renal function can be made pre-pregnancy, and therefore the newer classification of CKD will be used here.
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: 04 ) 450-459 25 EPHROL ening of maternal kidney function (9) (10) (11) (12) (13) , although the risk of preeclampsia (10%-20%) remains greater than that for pregnant women without CKD (5%) (4, 14) . Recently successful fetal outcomes have been reported to be as high as 98% (15) ; however, rates of preterm delivery (11%-40%) and low birth weight (5%-26%) continue to be higher than in healthy controls (4, 6, (16) (17) (18) , even in those with CKD stage 1 (19) , including those with isolated microscopic hematuria (19) . A systematic review has demonstrated that complications are seen more frequently in women with the following adverse risk factors (20) .
Proteinuria
Some authors report that the presence of proteinuria in pregnancy is associated with a worse outcome (21) (22) (23) . Up to 30% of women with CKD without proteinuria pre-pregnancy develop significant proteinuria [300 mg/24 hours or 30 mg/ μmol creatinine (24) ] during pregnancy (25) due to increased GFR and alterations in renal handling. Urinary protein loss may become nephrotic, particularly in those with preexisting proteinuria (25) . Women with pre-pregnancy proteinuria should be warned of the possible requirement for thromboprophylaxis, which is currently advised to be commenced with proteinuria (>3 g/24 hours), and with serum albumin <20 g/dL in nonpregnant women or serum albumin of <25 g/dL in pregnant women, because of theoretical urinary losses of antithrombin and associated changes in coagulation factors (4) . Dosing of low-molecular-weight heparin should be prescribed according to the level of renal impairment.
Hypertension
The absence of hypertension, almost regardless of renal function, predicts the best outcome; however, hypertension may worsen or arise de novo in pregnancy and is associated with more complications in women with CKD (18, 26) . Women may need to take multiple antihypertensive agents to control their blood pressure. The distinction between progressive hypertension with proteinuria and preeclampsia may be difficult, and women with CKD should be warned about potential clinical uncertainties which may require admission. Serial growth scans are often performed to help guide decisions about delivery.
Lupus nephritis
Cyclophosphamide is traditionally the first-line agent for active lupus nephritis. Its use has previously been associated with ovarian failure (27) . However, it has now been demonstrated that total dose of cyclophosphamide and age >32 are the most important predictors of anovulation (28, 29) . Gonadotropin-releasing hormone (GnRH) agonists are occasionally used preemptively for preservation of ovarian function in women undergoing chemotherapy with cyclophosphamide (30) . However, given the association with premature menopause, women with prior exposure to cyclophosphamide should be referred promptly to infertility specialists if there are delays in conceiving thereafter. Women with lupus nephritis tend to have worse pregnancy outcomes than women with systemic lupus erythematosus (SLE) without nephritis (31) , and also compared with women with the same level of renal impairment with different etiologies of CKD (20, 25) . The reason for this finding is unclear, but may be related to the systemic nature of the disease and is probably independent of class of lupus nephritis (32) . A systematic review reported successful pregnancy outcomes in 77%, but rates of lupus nephritis flare (16%), extrarenal flare (26%), preeclampsia (8%), preterm delivery (39%) and intrauterine growth restriction (13%) remain high (32) . Preeclampsia often occurs earlier in women with lupus nephritis than in those with SLE without nephritis and is responsible for many iatrogenic preterm deliveries, although spontaneous preterm labor is also frequently seen (31) . Predictors of poor pregnancy outcome in women with lupus nephritis include level of renal impairment, hypertension (31) , low complement levels (22) and disease activity at conception (33) . Women whose lupus nephritis is quiescent for 6 months prior to conception have better pregnancy outcomes compared with those with active disease (34, 35) . A period of 3-6 months following changes in medication is Renal disease activity appears to be more common postpartum (36) , whereas extrarenal disease flare occurs predominantly in the second and third trimesters (37, 38) . Woman need to be instructed not to stop their medication once conceiving, as flare is also associated with worse pregnancy outcome. Pregnancy-associated decline in renal function does not appear to be greater than in women with other etiologies of CKD (22, 39) . and following renal transplantation, pregnancy outcomes in women with lupus nephritis are reported to be similar to those who had undergone renal transplantation for other reasons (40) . Pulmonary hypertension (defined as a resting pulmonary arterial pressure of >25 mm Hg in the nonpregnant state) is an absolute contraindication to pregnancy and will need to be excluded if there are any features in the history or examination to suggest this. Mortality rate in secondary pulmonary hypertension is 25%-30% (41) . Women with lupus nephritis should also be assessed for the presence of anti-Ro and anti-La antibodies due to their associations with congenital heart block and neonatal lupus. Women with SLE and concurrent antiphospholipid antibodies (aPLs) have a higher rate of fetal loss (33, 42) , and complications such as fetal growth restriction and preterm delivery have also been reported to occur 3 times more often when aPLs are positive (43) . Suggested investigations pre-pregnancy for women with lupus nephritis are listed in Table II .
CKD stages 3 and 4
CKD stages 3 and 4 are defined as eGFR <60 ml/min per 1.73 m 2 and eGFR <30 ml/min per 1.73 m 2 , with creatinine usually >100 μmol/L and creatinine >180 μmol/L, respectively. There is a reduction in fertility with increasing severity of renal impairment (44) , and fetal loss is greater, with frequent early and late miscarriages (45) (46) (47) (48) (49) . A useful early guide to the success of an individual pregnancy is the adaptation to increased GFR (50) . If creatinine does not fall in the late first / early second trimester it is suggestive of future complications. Preeclampsia may occur in up to 40%-60% of women with CKD stage 3 or 4 (4, 46, 47) , which may be early and severe. Prematurity is common (39%-64%) (4, (45) (46) (47) (48) (49) , and despite major advances in neonatal care, very preterm infants frequently have sensory impairment and intellectual disability. It is therefore important to highlight in prenatal counseling the association of very preterm delivery with long-term disability. Up to 50% of women have a decline in renal function either during pregnancy or postpartum, and in approximately one third, it is persistent (4, 47) particularly in those with worse baseline renal function. Temporary renal deterioration may require iatrogenic preterm delivery to preserve renal function (51) but with the risk of serious neonatal consequences. Important predictors of permanent deterioration of renal disease in women with CKD stages 3-5 are the combined presence pre-pregnancy of GFR of less than 40 ml/min per 1.73 m 2 and proteinuria exceeding 1 g/24 hours (39).
CKD stage 5
Stage 5 CKD is defined as eGFR <15 ml/min per 1.73 m 2 or being on dialysis. Many women on dialysis are oligomenorrheic or amenorrheic, but up to 1 in 200 women of child- 54% (4, 48, 53, 54) ; however, more recent series suggest some improvement, including reports of 80%-90% successful pregnancy outcomes in small series of women on dialysis (55) (56) (57) (58) . Preeclampsia occurs in the majority and is associated with worse outcome (58) . Mean gestation at delivery is between 32 and 33 weeks (59-61). Those women not already on dialysis have a high risk of deterioration of renal disease, likely to require renal replacement therapy. The lifestyle implications of dialysis and its associated shortened life expectancy need to be explained in detail, particularly with regards to bringing up small children. An association between high maternal urea levels and preterm delivery and low birth weight has been described (62); therefore it is recommended that hemodialysis frequency be increased to 5-7 times per week, aiming for more than 20 hours to achieve more normal biochemistry and avoid marked shifts in intravascular volume. This regimen appears to have been successful in several cases (55, 57, 59, 61, 63) , with even twin pregnancies being successfully supported (58) . One of the adverse effects of hemodialysis is the theoretical removal of progesterone from the dialysate, which may be associated with spontaneous preterm labor. An important consideration for these and many other CKD patients is that the obstetric services and nephrology/dialysis facilities need be on the same site. The number of pregnant individuals on peritoneal dialysis (PD) is approximately 2 to 3 times lower than that of those on hemodialysis (64, 65) . This is postulated to be due to the hypertonic peritoneal milieu and volume of fluid in the abdominal cavity having adverse effects on the ovum or its transport down the fallopian tubes (44, 66) as well as previous episodes of peritonitis resulting in adhesions and failure of implantation (65) . Babies born to mothers on PD have higher birth weights compared with those on hemodialysis, there is less preeclampsia but premature labor and peritonitis are more common (66) . The majority of women who conceive while on PD are often changed to hemodialysis due to perceived issues of volume, inadequate clearance and less experience. Anemia in women on dialysis has been shown to be associated with fetal or neonatal loss and preterm delivery (58, 62) . Women who already require erythropoiesis-stimulating agents are likely to need larger doses throughout gestation, and some women may develop erythropoietin deficiency during pregnancy due to failure of endogenous synthesis to meet the increased demands.
Transplantation
With the recovery of renal function following renal transplantation, both fertility and libido are restored (67) . There is no conclusive evidence that pregnancy increases the risk of graft rejection or causes a deterioration in graft function (68) (69) (70) (71) (72) , other than in those with moderate to severe renal impairment (73) . Unfortunately, women with excellent graft function and "normal" GFR still have an increased risk of preeclampsia (26, 70, 71, 74) , potentially due to previous endothelial injury or undetectable graft fibrosis. A recent meta-analysis has highlighted the increased risk of gestational diabetes in pregnant renal transplant recipients, as well as elevated rates of preterm delivery compared with general US population data (74) . Again women must be advised not to stop any immunosuppressive agents without medical advice on conception lest they precipitate acute rejection or sensitization. Urinary tract infection is common with renal transplants, and women should be advised to seek medical advice at the first suspicion of symptoms. Monthly screening for asymptomatic bacteruria is advised by European Best Practice Guidelines, and for those with recurrent infection, prophylaxis throughout the rest of pregnancy is recommended (75) . Women with renal transplants should be reassured that they can have normal vaginal deliveries and that the allograft will not be damaged by pregnancy or delivery due to its anatomical position, although cesarean section continues to be the most common delivery mode in these women (74) .
Hereditary renal disease

Reflux nephropathy
Reflux nephropathy complicates pregnancy due to the increased frequency of urinary tract infections (UTIs). If there is evidence of vesicoureteric reflux in the mother, this should be screened for in the child as soon as possible after birth (76) , though some cases may be detected in utero.
Adult polycystic kidney disease
Women with adult polycystic kidney disease (APKD) may also experience more UTIs, as well as bleeding into cysts. It is very unlikely that the size of the kidneys will preclude pregnancy. Women with known APKD should be advised of the genetic risk to their offspring, although few contemplate termination.
Pregnancy Planning
Timing of conception
One of the essential components of pre-pregnancy counseling is a discussion of the timing of conception, the importance of which varies on an individual basis according to patient age, disease etiology and activity. Details for specific disease conditions are shown in Table III .
Medication review
Another valuable component of pre-pregnancy counseling for women with CKD is a medication review. Several drugs commonly used by nephrologists and in primary care are teratogenic or have consequences for the fetus later in pregnancy.
Immunosuppression
Despite the relative state of immune tolerance consequent to pregnancy, immunosuppression for women with renal transplant or glomerulonephritis should usually be continued. The safety of commonly used agents is reviewed in Table IV .
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers
First trimester exposure to angiotensin-converting enzyme (ACE) inhibitors is associated with a 2.7-fold increase in congenital malformations (84) . Abnormalities include cardiovascular, central nervous system and renal defects. With second or third trimester exposure, very significant fetal complications including growth restriction, oligohydramnios, hypocalvaria, renal dysplasia, anuria, renal failure and often fetal death have been reported, and the use of ACE
TABLE III RECOMMENDED TIMING OF CONCEPTION FOR WOMEN WITH CHRONIC KIDNEY DISEASE (CKD)
Etiology of CKD Recommended timing of conception Explanation
Renal transplant 1 year posttransplant (Recommended by European Best Practice Guidelines (75))
• Delay is associated with better pregnancy and renal outcomes (69) • Allows for medication adjustments and to reduce the risk of acute graft rejection inhibitors or angiotensin II receptor blockers (ARB) is contraindicated beyond the first trimester in all women except those with scleroderma where the protection from a renal crisis outweighs the risk to the fetus from the drug (85) . Regarding first-trimester exposure, 3 possible approaches are available to women with CKD taking ACE inhibitors / ARBs considering pregnancy, which are shown in Table V .
Aspirin
Low-dose aspirin is reported to reduce the risk of preeclampsia in high-risk individuals by 17% (86) and has specifically been shown to be associated with favorable pregnancy outcomes in women with lupus nephritis (22) . Aspirin use (75 mg once daily) should be discussed with all women with CKD considering pregnancy and started preconception, or as early as possible in pregnancy, unless contraindicated.
conclusion
Women with CKD are a diverse group of individuals with a spectrum of pregnancy outcomes, from those with a minimal increase in risk of preeclampsia, to those very unlikely to have a normal pregnancy course. One of the most useful guides to pregnancy outcome is obstetric history, as future pregnancies often mirror previous pregnancies. Women with significant kidney disease and a high risk of pregnancy or kidney-related problems should be counseled pre-pregnancy and followed during pregnancy in specialist centers where high-risk obstetric and renal care are both offered. 
